Biotechnology Assets S.A. (BST) — Cash Flow-to-Debt Ratio
Biotechnology Assets S.A. (BST) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2025, meaning its operating cash flow of €658.13K could theoretically repay 0% of its total liabilities (€7.01 Million) in one year. Check Biotechnology Assets S.A. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotechnology Assets S.A. Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Biotechnology Assets S.A. across 11 annual periods. Also explore Biotechnology Assets S.A. total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Biotechnology Assets S.A. (2014–2024)
Year-by-year debt coverage analysis for Biotechnology Assets S.A.. For market capitalisation and broader financial context, see Biotechnology Assets S.A. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-73.85K | €8.17 Million | ▼ -290.7% |
| 2023 | 0.00x | €47.74K | €10.08 Million | ▲ +104.0% |
| 2022 | -0.12x | €-1.73 Million | €14.60 Million | ▼ -22.8% |
| 2021 | -0.10x | €-1.50 Million | €15.54 Million | ▼ -118.0% |
| 2020 | 0.54x | €8.79 Million | €16.37 Million | ▲ +401.6% |
| 2019 | -0.18x | €-15.16 Million | €85.11 Million | ▲ +20.6% |
| 2018 | -0.22x | €-13.02 Million | €58.04 Million | ▼ -1104.4% |
| 2017 | 0.02x | €213.49K | €9.56 Million | ▼ -93.4% |
| 2016 | 0.34x | €2.71 Million | €8.02 Million | ▲ +1447.8% |
| 2015 | 0.02x | €158.16K | €7.23 Million | ▲ +150.5% |
| 2014 | -0.04x | €-303.79K | €7.01 Million | — |